We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cordis, Abbott Continue Battle Over Stent Patents

Law360 (June 13, 2007, 12:00 AM EDT) -- Johnson & Johnson subsidiary Cordis Corp. has struck the most recent blow in its battle with Abbott Laboratories over the $2 billion annual U.S. market for drug-eluting coronary stents, filing a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.